News Headlines

  1. CISCRP Announces 2nd Annual Virtual Fitness Challenge To Recognize Medical Heroes 4/2/2020

    On April 15, the Center for Information & Study on Clinical Research Participation (CISCRP) will be initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global clinical research community together to express their appreciation for all “Medical Heroes” – medical and healthcare professionals, researchers and study volunteers.  CISCRP invites the public to participate in this free month-long virtual fitness opportunity.

  2. Amarex, An NSF International Company, Executes Five Rush COVID-19 Related Submissions To The FDA 4/2/2020

    In early March 2020, Amarex Clinical Research LLC, an NSF International company, executed a rush submission of an emergency use Investigational New Drug (IND) application to add COVID-19 as a new indication for CytoDyn’s monoclonal antibody product, Leronlimab.

  3. Spring Bank Provides Update On Business Operations & Clinical Program Progress During COVID-19 Pandemic 4/2/2020

    Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today provided an update on the company’s business operations in response to and as a result of the global COVID-19 pandemic.

  4. ERT Enables Clinical Trial Continuity Through At-Home Respiratory Solutions 4/1/2020

    ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits.

  5. Saama Makes State-Of-The-Art Clinical Analytics Platform Available To Integrate Data From All Organizations Investigating COVID-19 Treatments 3/30/2020

    Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium.

  6. Free Research Compliance Resources During COVID-19 Crisis 3/26/2020

    Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis. This includes complimentary transfer of IRB oversight, access to a new version of Forte eRegulatory management software, eReg Lite, and a dedicated “Ask Advarra” resource for rapid guidance on emerging issues impacted by COVID-19.

  7. New Website A Free Resource for Researchers, Patients On COVID-19 Trials 3/24/2020

    CoronaClinicalTrials.com curates study information from government sources to provide a source of credible information on coronavirus clinical studies. The website automatically syncs clinical trial information from ClinicalTrials.gov and includes educational resources from CISCRP.

  8. CDMO Berkshire Sterile Manufacturing To Fill Initial COVID-19 Injectables For Clinical Trials 3/24/2020

    The Berkshires, known for its rich culture and charming green mountain towns has now become a manufacturer of novel treatments and medications to aid in the ongoing pandemic.

  9. CluePoints Central Statistical Monitoring Supports Business Continuity As Coronavirus Impacts Clinical Trial Operations 3/18/2020

    CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.

  10. Signant Health Appoints Ian Jennings As Chief Commercial Officer 3/4/2020

    Signant Health is proud to announce the appointment of Ian Jennings as Chief Commercial Officer to help support the next phase of Signant Health’s growth as a leading advocate of patient focused technology solutions.